Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary T Mack

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cells|August 7, 2019
Identifying Cancers Impacted by CDK8/19Igor B Roninson, Balázs Győrffy, Zachary T Mack, et al.
Cancers|March 28, 2025
Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell CarcinomaWade C Barton, Asha Kumari, Zachary T Mack, et al.
Biochemical Pharmacology|October 13, 2020
Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assemblyB Celia Cui, Vitali Sikirzhytski, Marina Aksenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2024
Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitorsXiaokai Ding, Jiaxin Liang, Amanda C Sharko, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022
Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivoXiaokai Ding, Amanda C Sharko, Martina S J McDermott, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cells|August 7, 2019
Identifying Cancers Impacted by CDK8/19Igor B Roninson, Balázs Győrffy, Zachary T Mack, et al.
Cancers|March 28, 2025
Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell CarcinomaWade C Barton, Asha Kumari, Zachary T Mack, et al.
Biochemical Pharmacology|October 13, 2020
Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assemblyB Celia Cui, Vitali Sikirzhytski, Marina Aksenova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2024
Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitorsXiaokai Ding, Jiaxin Liang, Amanda C Sharko, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022
Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivoXiaokai Ding, Amanda C Sharko, Martina S J McDermott, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Pageof 1